Louis Philipson to Vascularized Composite Allotransplantation
This is a "connection" page, showing publications Louis Philipson has written about Vascularized Composite Allotransplantation.
Connection Strength
0.381
-
307.5: Modified Approach Allowed for Improved Islet Allotransplantation Into Pre-vascularized Sernova Cell PouchTM Device - Preliminary Results of the Phase I/II Clinical Trial at University of Chicago. Transplantation. 2021 Dec 01; 105(12 Suppl 1):S25.
Score: 0.197
-
Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation. Cell Transplant. 2021 Jan-Dec; 30:9636897211001774.
Score: 0.185